FAU to Host Events for Women's History Month
Florida Atlantic University will host events at Boca Raton, Davie, Fort Lauderdale, and Jupiter campuses to celebrate Women's History Month.
The Osher LLI at FAU Jupiter Presents Barry Weinberg
The Osher LLI at FAU will present a lecture by Barry Weinberg, on Tuesday, March 17 at 4:30 p.m. in the Osher LLI complex at FAU Jupiter.
Osher LLI at FAU Announces Spring Course Schedule
The Osher Lifelong Learning Institute at Florida Atlantic University in Jupiter has announced its course offerings for the spring semester, which begins Tuesday, March 14.
Neighborhood Features and Genetic Risk Interact to Affect Cognition
A new FAU study is the first to examine how neighborhood environment affects cognition in older adults based on their genetic risk for Alzheimer's disease and dementia.
Osher Lifelong Learning Institute at FAU Presents Terry Virts
The Osher LLI at FAU in Jupiter will present a lecture by Terry Virts, on Wednesday, March 4 at 7 p.m.
Many Teens are Digital Dating Abuse Victims; Boys Get the Brunt of It
It's almost Valentine's Day, but there is nothing romantic about new research illuminating how teen dating abuse is manifesting online. A study explores the problem among U.S. middle and high school à£à£Ö±²¥Ðã.
Osher LLI at FAU Presents William Sharfman, M.D.
The Osher LLI at FAU in Jupiter will present a lecture by William Sharfman, M.D., on Wed., Feb. 26 at 7 p.m.
Osher LLI at FAU Presents Douglas Brinkley
The Osher LLI at FAU in Jupiter will present a lecture by Douglas Brinkley, CNN presidential historian and author, on Tuesday, Feb. 25 at 7 p.m. in the Osher LLI complex at FAU Jupiter.
FAU to Host Events in Honor of Black/African American History Month
Florida Atlantic University will celebrate Black/African American History Month with a series of events throughout the month of February at its Boca Raton, Jupiter and Broward campuses.
Study Shows New Way to Treat Stroke Using an Already FDA-Approved Drug
Researchers from FAU's Schmidt College of Medicine are the first to report on the neuroprotective properties of granulocyte colony-stimulating factor, an already FDA-approved drug.